Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes
- 31 December 2001
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 44 (3), 195-206
- https://doi.org/10.1053/pcad.2001.29143
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 2001
- Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary SyndromesJAMA, 2000
- ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and RecommendationsCirculation, 2000
- Platelet GPIIb-IIIa blockersThe Lancet, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable AnginaCirculation, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Toward a New Frontier in Myocardial Reperfusion TherapyCirculation, 1998
- The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapyEuropean Heart Journal, 1995